tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Cocrystal Pharma showcases CDI-988, antiviral for norovirus infection
PremiumThe FlyCocrystal Pharma showcases CDI-988, antiviral for norovirus infection
19d ago
Cocrystal Pharma receives IND clearance for challenge study of CDI-988
Premium
The Fly
Cocrystal Pharma receives IND clearance for challenge study of CDI-988
23d ago
Cocrystal Pharma reports Q2 EPS (20c), consensus (30c)
Premium
The Fly
Cocrystal Pharma reports Q2 EPS (20c), consensus (30c)
2M ago
Cocrystal Pharma price target lowered to $6 from $7 at H.C. Wainwright
PremiumThe FlyCocrystal Pharma price target lowered to $6 from $7 at H.C. Wainwright
3M ago
Cocrystal Pharma’s CDI-988 Featured at Military Symposium
Premium
Company Announcements
Cocrystal Pharma’s CDI-988 Featured at Military Symposium
4M ago
Cocrystal Pharma’s CC-42344 Shows Strong Antiviral Potency
Premium
Company Announcements
Cocrystal Pharma’s CC-42344 Shows Strong Antiviral Potency
4M ago
Cocrystal Pharma Presents to Investment Community
PremiumCompany AnnouncementsCocrystal Pharma Presents to Investment Community
5M ago
Cocrystal Pharma Approves 2025 Equity Incentive Plan
Premium
Company Announcements
Cocrystal Pharma Approves 2025 Equity Incentive Plan
6M ago
Cocrystal Pharma reports FY24 EPS ($1.72), consensus ($1.93)
Premium
The Fly
Cocrystal Pharma reports FY24 EPS ($1.72), consensus ($1.93)
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100